Incidence of Postoperative Delirium in Cancer Patients After Laparoscopic Surgery in Trendelenburg Position
Delirium, Anesthesia
About this trial
This is an interventional diagnostic trial for Delirium focused on measuring Delirium, Anesthesia, Surgical Oncology
Eligibility Criteria
Inclusion Criteria:
- Oncologic patients submitted to elective videolaparoscopic surgery in Trendelenburg position
- 18 years or older
- ASA lesser than 3
- period of at least 2 hours in Trendelenburg position
Exclusion Criteria:
- With absolute contraindication and related to spinal anesthesia
- With difficult airway prediction with possibility of awake intubation.
- With previous diagnosis of: cognitive disorder and / or depression.
- Chronic use of benzodiazepines (use during the last 12 weeks).
- Referred to perform the postoperative ICU.
- With diagnosis of anemia (Hemoglobin <10).
- With diagnosis of current infection.
- With renal disease with stage> G3a (glomerular filtration rate <45 ml / min / 1.73 m2.
- With body mass index (BMI) characterized by obesity (BMI> 30 kg / m2).
- With history of nausea / vomiting in previous anesthetic procedures.
- With diagnosis of malignant hyperthermia.
Sites / Locations
- A.C. Camargo Cancer Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Subarachnoid block
Spinal morphine
Subarachnoid block with hyperbaric bupivacaine 0,5% 3ml associate with morphine 50 mcg. A general anesthetic with fentanyl 3 mcg / kg + propofol 2 mg / kg + rocuronium 0.6 mg / kg will be performed. Anesthesia will be maintained with remifentanil (ng / ml) through Minto's pharmacokinetic model (BBraun infusion syringe - Perfusor® Space model) and desflurane (Fe%).
Spinal morphine with morphine 50 mcg. A general anesthetic with fentanyl 3 mcg / kg + propofol 2 mg / kg + rocuronium 0.6 mg / kg will be performed. Anesthesia will be maintained with remifentanil (ng / ml) through Minto's pharmacokinetic model (BBraun infusion syringe - Perfusor® Space model) and desflurane (Fe%).